Now based in Copenhagen, SB3000 ApS will have key operations in both the UK and Denmark.
Our science hub at DTU:
Swedish Biomimetics 3000 ApS
Diplomvej 381
2800 Kongens Lyngby
Denmark
Over the last several years, SB3000 has developed continuous manufacturing technology based on solid liquid-phase chemistry, including the development of a superior mixing technology using ultrasound to create a robust platform technology. This disruptive technology has already been proven in a proof of concept model.
Our precision engineering hub in Hethel:
Swedish Biomimetics 3000 Ltd,
Hethel Innovation Centre, Chapman Way,
Hethel, Norfolk, NR14 8FB
Great Britain
OUR PLATFORM
Swedish Biomimetics 3000 is at the forefront of creating a platform technology that will advance not only therapeutic peptide production but also any form of chemistry or process based on a solid-liquid phase interaction including chromatography.
We believe that the µLOT® process will speed up
development, reduce cost and enable the synthesis of drugs currently not economically or technically possible to produce. At present the process is applicable to 80% of the market. We are developing the technology to cover the remaining market by including novel peptide designs such as lipid- and antibody-conjugations.
SB3000 AB
Swedish based Swedish Biomimetics 3000 AB is a majority shareholder in SB3000 ApS, led by Lars Uno Larsson, a serial entrepreneur.
SB3000 AB is a pioneer in the field of biomimetics which is to find, develop and launch technologies inspired by nature and to apply them to today’s enviromental and climate change challenges .
SB3000 AB is also a majority investor in Swedish Biomimetics 3000 µMist Technologies Ltd, a disruptive innovative enviromental friendlier spray technology inspired by the Bombardier beetle. The µMist technology is set to disrupt a $200 billion spray market across a number of different industries.